BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+3.35%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.4B
AUM Growth
+$17.4B
(+0.42%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
90.2%
Holding
115
New
7
Increased
16
Reduced
13
Closed
14
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$28.6M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$20.8M |
| 3 |
AbCellera Biologics
ABCL
|
$19.8M |
| 4 |
Denali Therapeutics
DNLI
|
$17.3M |
| 5 |
Immunovant
IMVT
|
$16.3M |
Top Sells
| 1 |
argenx
ARGX
|
$63.4M |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$55.9M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$48.1M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$28.7M |
| 5 |
AnaptysBio
ANAB
|
$12M |
Sector Composition
| 1 | Healthcare | 99.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sera Prognostics
SERA
$129M
| $2.82M | 0.02% |
1,515,342
-262,093
| -15% | -$487K |
|
77
Vaxcyte
PCVX
$4.17B
| $2.49M | 0.01% |
48,885
| – | – |
|
78
Xencor
XNCR
$594M
| $2.48M | 0.01% |
123,127
| – | – |
|
79
KALA BIO
KALA
$105M
| $2.37M | 0.01% |
266,613
+150,400
| +129% | +$1.34M |
|
|
ACHL
80
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $2.33M | 0.01% |
2,557,149
| – | – |
|
81
Century Therapeutics
IPSC
$40.4M
| $2.3M | 0.01% |
1,149,340
| – | – |
|
|
AFMD
82
DELISTED
Affimed
AFMD
| $2.13M | 0.01% |
4,448,644
-2,148,186
| -33% | -$1.03M |
|
83
Perspective Therapeutics
CATX
$251M
| $2.09M | 0.01% |
7,639,703
+5,320,417
| +229% | +$1.46M |
|
84
Instil Bio
TIL
$196M
| $2.01M | 0.01% |
4,704,395
-569,394
| -11% | -$244K |
|
85
PMV Pharmaceuticals
PMVP
$82.1M
| $1.98M | 0.01% |
322,024
| – | – |
|
|
86
AnaptysBio
ANAB
$630M
| $1.91M | 0.01% |
106,197
-669,727
| -86% | -$12M |
|
|
PNT
87
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.67M | 0.01% |
249,968
-919,135
| -79% | -$6.13M |
|
|
ITOS
88
DELISTED
iTeos Therapeutics
ITOS
| $1.65M | 0.01% |
150,346
| – | – |
|
89
Leap Therapeutics
LPTX
$12M
| $1.62M | 0.01% |
1,172,175
| – | – |
|
90
Aligos Therapeutics
ALGS
$75.1M
| $1.55M | 0.01% |
2,076,400
| – | – |
|
91
Mersana Therapeutics
MRSN
$34.8M
| $1.38M | 0.01% |
1,086,115
| – | – |
|
92
Vor Biopharma
VOR
$253M
| $1.34M | 0.01% |
633,848
| – | – |
|
|
NVTA
93
DELISTED
Invitae Corporation
NVTA
| $1.07M | 0.01% |
1,764,546
-7,116,558
| -80% | -$4.31M |
|
94
Avidity Biosciences
RNA
$6.12B
| $1.06M | 0.01% |
166,347
-633,104
| -79% | -$4.04M |
|
|
BCEL
95
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $922K | 0.01% |
3,532,760
| – | – |
|
|
GTH
96
DELISTED
Genetron Holdings Limited ADS
GTH
| $370K | ﹤0.01% |
455,306
| – | – |
|
97
Protara Therapeutics
TARA
$125M
| $333K | ﹤0.01% |
199,671
| – | – |
|
98
Foghorn Therapeutics
FHTX
$298M
| $225K | ﹤0.01% |
45,027
| – | – |
|
99
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $34.3K | ﹤0.01% |
833,333
| – | – |
|
100
Allogene Therapeutics
ALLO
$249M
| – | – |
-1,576,901
| Closed | -$7.84M |
|